Doctronic

Name: Doctronic
Brand: Doctronic
Rating: 4.7 (567 reviews)

AI Native

Doctronic is a consumer-facing AI symptom-checking and medical Q&A platform that generates health guidance and summaries and offers optional escalation to licensed clinicians for diagnosis, treatment (including prescriptions) and telehealth visits, while also providing embeddable AI products for clinics and employer benefits and participating in a Utah pilot for AI-supported prescription renewals.

Est 2023|Valuation $206M|Raised $65M|2 Ref Customers

LinkedIn 13K|Web traffic 1.3M|FTEs 4|HQ New York, NY

Published Aug 15, 2026

01Common complaints

If an organization requires enterprise-grade security documentation (for example, SOC 2 Type II or ISO 27001) at the time of procurement: public materials reviewed did not surface those artifacts.
If the use case involves complex clinical decision-making or high-acuity triage: human-first clinical models are preferable for emergency or acute settings.
If the organization cannot tolerate model-manipulation or jailbreak risk: public reporting indicates that safety controls require ongoing effort.
If transparent, named clinician networks and clinician continuity are required: organizations that need named clinician identity and continuity may prefer established telehealth providers.
If a conservative brand messaging posture is required: organizations seeking to avoid controversy around “AI doctor” framing may prefer vendors that use “AI-assisted navigation” language and demonstrate extensive compliance artifacts.

- If an organization requires enterprise-grade security documentation (for example, SOC 2 Type II or ISO 27001) at the time of procurement: public materials reviewed did not surface those artifacts. - If the use case involves complex clinical decision-making or high-acuity triage: human-first clinical models are preferable for emergency or acute settings. - If the organization cannot tolerate model-manipulation or jailbreak risk: public reporting indicates that safety controls require ongoing effort. - If transparent, named clinician networks and clinician continuity are required: organizations that need named clinician identity and continuity may prefer established telehealth providers. - If a conservative brand messaging posture is required: organizations seeking to avoid controversy around “AI doctor” framing may prefer vendors that use “AI-assisted navigation” language and demonstrate extensive compliance artifacts.

Deal disqualifiers (poor fit)

Organizations requiring immediate production evidence of SOC 2 Type II / ISO 27001 or other mature trust-center artifacts
High-risk prescribing contexts outside constrained maintenance refill programs
Organizations unwilling to accept reputational risk from AI hallucinations or controversial framing of an AI as a medical authority

Publicly visible limitations and constraints

Geographic limitation: The prescription renewal functionality is described as a pilot available in Utah.
Formulary constraints: The Utah program references a defined formulary of maintenance medications in the public program materials.

Potential limitations inferred from user discussions and reporting

Susceptibility to jailbreaks and unsafe outputs (reported by security researchers).
Gaps in publicly available documentation of security certifications and clinician network details.
Limited presence on enterprise B2B review platforms (Gartner/G2/TrustRadius), which may reduce confidence for some procurement processes.

Roadmap (not verified)

The vendor’s blog indicates ongoing product changes and adjustments to tiering; specific roadmap items and timelines were not verifiable in the sources reviewed.

02Why they buy

Public signals indicating potential advantages

Notable consumer review volume and generally positive average consumer ratings on Trustpilot.
Low, simple consumer-facing pricing (stated $39 telehealth visit and free AI guidance entry point).
Active participation in a regulatory pilot in Utah for AI-supported prescription renewals, which differentiates the vendor’s operational scope in that jurisdiction.

Where competitors may be stronger

Publicly documented enterprise security certifications and mature procurement readiness.
More established clinical partnerships, clinician networks, and payer integrations.
Broader platform integrations (for example, EHR integration) depending on the competitor.

03Field reports

Review-platform availability note (B2B review sites)

Gartner Peer Insights: No substantive Doctronic listing or reviews were found in accessible search results during this review.
G2 / TrustRadius / Capterra: No substantive listings with detailed reviews were identified in accessible search results.
Trustpilot (consumer review platform): Doctronic has a substantial volume of consumer reviews with an overall high average rating, which provides more usable sentiment data than the B2B review platforms for this product.

- **Gartner Peer Insights:** No substantive Doctronic listing or reviews were found in accessible search results during this review. - **G2 / TrustRadius / Capterra:** No substantive listings with detailed reviews were identified in accessible search results. - **Trustpilot (consumer review platform):** Doctronic has a substantial volume of consumer reviews with an overall high average rating, which provides more usable sentiment data than the B2B review platforms for this product.

Trustpilot: positive feedback themes (examples)

On Trustpilot, reviewers commonly note:

Speed and convenience relative to in-person visits
Perceived thoroughness in some encounters
Clarity of Q&A and a clear flow from AI interaction to clinician visit

Representative excerpts visible on the Trustpilot page snapshot include user statements such as:

"I didn’t have to repeat or clarify any questions, and the answers I received were very clear..." (high-rating)
"This by far has been more thorough than any primary... specialist..." (high-rating)
"Exceptional experience. the AI portion was wonderful. The doctor was knowledgeable, professional..." (high-rating)

These comments indicate consumer satisfaction among some reviewers; however, Trustpilot sentiment can skew toward early adopters and is not a substitute for clinical validation.

On Trustpilot, reviewers commonly note: - Speed and convenience relative to in-person visits - Perceived thoroughness in some encounters - Clarity of Q&A and a clear flow from AI interaction to clinician visit Representative excerpts visible on the Trustpilot page snapshot include user statements such as: - "I didn’t have to repeat or clarify any questions, and the answers I received were very clear..." (high-rating) - "This by far has been more thorough than any primary... specialist..." (high-rating) - "Exceptional experience. the AI portion was wonderful. The doctor was knowledgeable, professional..." (high-rating) These comments indicate consumer satisfaction among some reviewers; however, Trustpilot sentiment can skew toward early adopters and is not a substitute for clinical validation.

Trustpilot: negative feedback prevalence and vendor responsiveness

Trustpilot shows a share of lower-rated reviews alongside higher-rated ones (for example, some very low-rated reviews in the snapshot). The company appears to reply to a subset of negative reviews within a short period in several instances. The presence of negative reviews indicates meaningful dissatisfaction for some users, and further sampling would be necessary to quantify specific complaint themes.

Reddit / community feedback: concerns and criticisms (examples)

Reddit threads include skeptical and risk-focused commentary, including:

Examples where users reported alarmist or anxiety-inducing AI outputs (for example, the AI suggesting a high probability of a serious neurological disease based on reported symptoms).
Questions about the clarity of who operates the service and clinician identity.
Privacy concerns about sharing health data with technology vendors.

These community observations reflect common failure modes for consumer health AI, such as over-triage, unclear clinician identity, and perceived opacity regarding data handling.

Reddit threads include skeptical and risk-focused commentary, including: - Examples where users reported alarmist or anxiety-inducing AI outputs (for example, the AI suggesting a high probability of a serious neurological disease based on reported symptoms). - Questions about the clarity of who operates the service and clinician identity. - Privacy concerns about sharing health data with technology vendors. These community observations reflect common failure modes for consumer health AI, such as over-triage, unclear clinician identity, and perceived opacity regarding data handling.

Hacker News

A targeted search did not return significant Hacker News discussion threads that were clearly relevant during this review.

Vendor/partner program evidence: Utah AI prescription renewal pilot

Critical evaluation:

This is a pilot; outcomes are not broadly published with independent evaluation in the public materials reviewed.
Public materials include claims about alignment rates with clinicians; however, study methodology, sampling, and external validation are not clearly documented in the accessible sources.

Utah’s Department of Commerce announced a partnership involving Doctronic and described a pilot program for AI-assisted prescription renewals that tracks outcomes such as refill timeliness, adherence, patient satisfaction, safety outcomes, and cost impacts. Critical evaluation: - This is a pilot; outcomes are not broadly published with independent evaluation in the public materials reviewed. - Public materials include claims about alignment rates with clinicians; however, study methodology, sampling, and external validation are not clearly documented in the accessible sources.

Academic-style benchmarking claim (preprint)

An academic preprint reports benchmarking involving Doctronic compared with clinicians.

Critical evaluation:

Preprints are typically not peer-reviewed at time of posting. Important evaluation points include study design, patient selection, real-world representativeness, conflict of interest and funding disclosures, and whether clinicians were blinded.

Recommendation: Treat such preprints as directional evidence rather than definitive clinical proof until validated in peer-reviewed literature or independent audits.

An academic preprint reports benchmarking involving Doctronic compared with clinicians. Critical evaluation: - Preprints are typically not peer-reviewed at time of posting. Important evaluation points include study design, patient selection, real-world representativeness, conflict of interest and funding disclosures, and whether clinicians were blinded. Recommendation: Treat such preprints as directional evidence rather than definitive clinical proof until validated in peer-reviewed literature or independent audits.

What’s missing

Doctronic’s public materials include organizational marketing pages and pilot documentation, but detailed independent case studies with transparent methodology and reproducible metrics were not prominent in the accessible materials reviewed.

04Best fit

Best-fit segments

Consumers (primary ICP)

Individuals seeking timely guidance for non-emergency symptoms, lab interpretation, medication questions, and initial triage decisions.
Cost-sensitive users who prefer a predictable telehealth price point.

Clinics and practices (lightweight web embed ICP)

Small-to-mid practices looking to add an after-hours triage or Q&A layer to reduce call volume.
Practices comfortable implementing disclaimers and escalation protocols and accepting the reputational tradeoffs associated with AI outputs.

Employers and benefits programs (secondary ICP)

Self-insured or cost-focused employers seeking to reduce unnecessary urgent care or emergency department utilization.
Employers with distributed workforces where access and convenience are prioritized.

1) Consumers (primary ICP) - Individuals seeking timely guidance for non-emergency symptoms, lab interpretation, medication questions, and initial triage decisions. - Cost-sensitive users who prefer a predictable telehealth price point. 2) Clinics and practices (lightweight web embed ICP) - Small-to-mid practices looking to add an after-hours triage or Q&A layer to reduce call volume. - Practices comfortable implementing disclaimers and escalation protocols and accepting the reputational tradeoffs associated with AI outputs. 3) Employers and benefits programs (secondary ICP) - Self-insured or cost-focused employers seeking to reduce unnecessary urgent care or emergency department utilization. - Employers with distributed workforces where access and convenience are prioritized.

Roles and personas

End users: patients and consumers
Economic buyers (B2B): benefits leaders, practice owners, operations leaders
Influencers: compliance, legal, clinical leadership, security teams

Qualification criteria (good fit)

Clear non-emergency guidance use cases
Established escalation pathways and safety messaging
Ability to implement governance such as disclaimers, monitoring and audit logs

05The pitch

What the product does (core value proposition)

Doctronic is a consumer-facing AI symptom-checking and medical Q&A product that generates health guidance and summaries, with an option to escalate into a telehealth visit with a licensed clinician for diagnosis and treatment actions (for example, prescriptions and visit notes). Doctronic also offers organizational products (for example, embedding its AI on practice websites and employer/benefits positioning) and is participating in a Utah state pilot program for AI-supported prescription renewals.

Target market and positioning

Primary (observed): Direct-to-consumer users seeking rapid, low-friction health guidance, triage, and an on-demand telehealth pathway.
Secondary (observed): Clinics and practices that may embed Doctronic’s AI on their websites, and employers positioning it as an always-available benefit.
Positioning theme: Marketed as a fast, anonymous, free AI-powered symptom checker with optional escalation to human clinicians; in Utah, the product is participating in a regulatory pilot related to prescription renewals.

- **Primary (observed):** Direct-to-consumer users seeking rapid, low-friction health guidance, triage, and an on-demand telehealth pathway. - **Secondary (observed):** Clinics and practices that may embed Doctronic’s AI on their websites, and employers positioning it as an always-available benefit. - **Positioning theme:** Marketed as a fast, anonymous, free AI-powered symptom checker with optional escalation to human clinicians; in Utah, the product is participating in a regulatory pilot related to prescription renewals.

Get a comprehensive analysis of Doctronic including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →